The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Topiramate and Psychiatric Adverse Events in Patients with Epilepsy
Abstract
Summary: Purpose: The aim of this study was to determine the prevalence of psychiatric adverse events (PAEs) in patients with epilepsy treated with topiramate (TPM). Classification, relation to TPM dosing, and outcome were evaluated to identify a patient profile at risk of developing PAEs. Methods: We evaluated the data of the first consecutive and prospectively collected patients in therapy with TPM. Results: Follow‐up information was available for 431 patients. PAEs occurred in 103 (23.9%) patients; M/F ratio, 55:48; mean age (±SD), 36.5 ± 11.2. In 46 (10.7%) patients, an affective disorder developed; in 16 (3.7%), a psychotic disorder; in 24 (5.6%), aggressive behavior with or without irritability; in 17 (3.9%), other behavior abnormalities such as agitated behavior, anger/hostility behavior, or anxiety. High starting dose and rapid titration schedule were relevant for the development of PAEs. Family psychiatric history and family history of epilepsy, personal history of febrile convulsions, psychiatric history, and presence of tonic–atonic seizures were found to be significant risk factors. Low seizure frequency before starting TPM and TPM/lamotrigine coadministration had a protective effect for PAEs. Conclusions: We found that PAEs associated with TPM were related to the titration schedule of the drug and that a unique patient profile is suggested by the clinical history.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Epilepsy: A Comprehensive Textbook
(1998) · Archives of Neurology · doi:10.1001/archneur.55.10.1373 · Cited by 452
A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome
Sachdeo, R. C., Glauser, T. A., Ritter, F., Reife, R., Lim, P., Pledger, G., & the Topiramate YL Study Group (1999) · Neurology · doi:10.1212/wnl.52.9.1882 · Cited by 380
Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
Martin, R., Kuzniecky, R., Ho, S., Hetherington, H., Pan, J., Sinclair, K., Gilliam, F., & Faught, E. (1999) · Neurology · doi:10.1212/wnl.52.2.321 · Cited by 369
Privitera, M., Fincham, R., Penry, J., Reife, R., Kramer, L., Pledger, G., & Karim, R. (1996) · Neurology · doi:10.1212/wnl.46.6.1678 · Cited by 339
A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures
Biton, V., Montouris, G. D., Ritter, F., Riviello, J. J., Reife, R., Lim, P., Pledger, G., & the Topiramate YTC Study Group (1999) · Neurology · doi:10.1212/wnl.52.7.1330 · Cited by 295
Faught, E., Wilder, B. J., Ramsay, R. E., Reife, R. A., Kramer, L. D., Pledger, G. W., & Karim, R. M. (1996) · Neurology · doi:10.1212/wnl.46.6.1684 · Cited by 289
Aldenkamp, A. P., Baker, G., Mulder, O. G., Chadwick, D., Cooper, P., Doelman, J., Duncan, R., Gassmann‐Mayer, C., de Haan, G. J., Hughson, C., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00322.x · Cited by 197
Trimble, M. (1991) · Medical Entomology and Zoology · Cited by 185
Self-citationSafety of Topiramate: Adverse Events and Relationships to Dosing
Shorvon, S. D. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb06029.x · Cited by 184
Cited by
Adverse effects of antiepileptic drugs
Perucca, P., & Gilliam, F. G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70153-9 · Cited by 694
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy
Mula, M., & Sander, J. W. (2007) · Drug Safety · doi:10.2165/00002018-200730070-00001 · Cited by 306
Self-citationEpilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
Brodie, M. J., Besag, F., Ettinger, A. B., Mula, M., Gobbi, G., Comai, S., Aldenkamp, A. P., & Steinhoff, B. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012021 · Cited by 288
Self-citationElger, C., Halász, P., Maia, J., Almeida, L., Soares‐da‐Silva, P., & on behalf of the BIA‐2093‐301 Investigators Study Group (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01946.x · Cited by 252
Metadata
- Authors
- Mula, M., Trimble, M. R., Lhatoo, S. D., & Sander, J. W. A. S.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2003-05
- Volume
- 44
- Issue
- 5
- Pages
- 659-663
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2086940719
- Cited by
- 254
- References
- 15
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topiramate and Psychiatric Adverse Events in Patients with Epilepsy. https://app.cochat.ai/papers/10.1046/j.1528-1157.2003.05402.x
- The paper
- Mula, M., Trimble, M. R., Lhatoo, S. D., & Sander, J. W. A. S. (2003). Topiramate and Psychiatric Adverse Events in Patients with Epilepsy. Epilepsia. https://doi.org/10.1046/j.1528-1157.2003.05402.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.